A pharmacovigilance system for treatment access and medical donation programs: The Max Foundation experience

Table 1 Number of Glivec® users and adverse event reports by year from countries with a Max-Station*

Country	2013		2014		2015		2016
Country	No. of Users	AE Reports	No. of Users	AE Reports	No. of Users	AE Reports	No. of Users	AE Reports
India	18,003	1669	18,434	1821	19,117	1839	18,210	1990
Thailand	2096	331	2255	317	2496	207	2620	238
South Africa	756	128	851	163	727	95	604	40
Mexico	885	97	937	106	889	110	822	71
Chile	185	89	198	77	220	61	245	78
Uzbekistan	701	68	767	65	787	119	973	41
Bolivia	159	54	173	34	197	60	223	108
Philippines	322	40	297	67	271	41	258	33
Guatemala	201	36	224	39	255	40	273	39
Honduras	184	27	213	60	224	35	253	47
Paraguay	110	27	102	21	108	18	118	25
Jamaica	83	17	87	14	86	18	96	18
Ecuador	38	12	32	7	28	11	25	7
Malaysia	218	12	247	44	266	30	261	20
Argentina	58	11	56	9	54	9	50	12
El Salvador	151	10	161	14	174	10	177	24
Dominican Republic	137	7	115	13	111	10	104	7
Nicaragua	69	5	82	10	104	13	120	20
Peru	59	5	58	10	52	10	45	7
Bahamas	6	1	5	0	6	0	7	1
Total	24,422	2646	25,294	2891	26,172	2736	25,484	2826

^*Countries with a Max-Station (MS) include those countries where MS call the patients for follow up and otherwise interact with the physician

ISSN: 1744-8603